Print

MediGene AG (DX:MDG) Halts Trials In Vaccine Partnered With Aventis S.A. (AVE) 
10/19/2005 5:11:19 PM

German biotechnology company MediGene AG (MDG.XE) has halted trials in an early-stage vaccine being tested to treat malignant melanoma, one of four products in its portfolio.
//-->